Cardiac magnetic resonance of hypertrophic heart phenotype: A review

Cardiac magnetic resonance of hypertrophic heart phenotype: A review

Hypertrophic heart phenotype is characterized by an abnormal left ventricular (LV) thickening. A hypertrophic phenotype can develop as adaptive response in many different conditions such as aortic stenosis, hypertension, athletic training, infiltrative heart muscle diseases, storage disorders and me...

Full description

Bibliographic Details
Main Authors:	Davide Tore, Riccardo Faletti, Clara Gaetani, Elena Bozzo, Andrea Biondo, Andrea Carisio, Francesca Menchini, Maria Miccolis, Francesco Pio Papa, Martina Trovato, Paolo Fonio, Marco Gatti
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Heliyon
Subjects:	CMR HCM Cardiac hypertrophy Amyloidosis Sarcoidosis Anderson-fabry disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023045449

Similar Items

Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis
by: Andrea Ponsiglione, et al.
Published: (2022-05-01)

Automatic Identification of Patients With Unexplained Left Ventricular Hypertrophy in Electronic Health Record Data to Improve Targeted Treatment and Family Screening
by: Arjan Sammani, et al.
Published: (2022-04-01)

NEXT GENERATION SEQUENCING HELPS IN DIFFERENTIAL DIAGNOSIS OF PATHOLOGICAL LEFT VENTRICULAR HYPERTROPHY IN ELITE ATHLETES
by: O S Chumakova, et al.
Published: (2017-12-01)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
by: Lynne K. Williams, et al.
Published: (2017-08-01)

Gene therapy in Anderson-Fabry disease. State of the art and future perspectives
by: Giorgio Spiniello, et al.
Published: (2020-08-01)

Sepsis-induced suicidal left ventricular in a patient with hypertrophic cardiomyopathy/hypertrophic obstructive cardiomyopathy
by: K Roshan Rao, et al.
Published: (2022-01-01)

Atypical Distribution of Late Gadolinium Enhancement of the Left Ventricle on Cardiac Magnetic Resonance in Classical Anderson-Fabry Disease
by: Shusuke Kasuya, et al.
Published: (2016-01-01)

Short-axis cine cardiac magnetic resonance images-derived radiomics for hypertrophic cardiomyopathy and healthy control classification
by: LIU Qiming, et al.
Published: (2024-01-01)

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis
by: Niki Lama, et al.
Published: (2022-03-01)

Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy
by: Min-Chi Ku, et al.
Published: (2021-05-01)

Sarcoidosis: Pitfalls and Challenging Mimickers
by: Naureen Narula, et al.
Published: (2021-01-01)

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
by: Dong T, et al.
Published: (2023-04-01)

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
by: Lazar Velicki, et al.
Published: (2020-12-01)

Sex Differences in Anderson–Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women
by: Denise Cristiana Faro, et al.
Published: (2023-09-01)

Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance
by: Kamil Stankowski, et al.
Published: (2023-05-01)

Transcriptional regulation of cardiac genes balance pro- and anti-hypertrophic mechanisms in hypertrophic cardiomyopathy
by: Nina Gennebäck, et al.
Published: (2012-06-01)

Cardiac “hypertrophy” phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography
by: Aaisha Ferkh, et al.
Published: (2023-07-01)

Fabry disease, a complex pathology not easy to diagnose
by: Paolo Colomba, et al.
Published: (2015-12-01)

Myocardial deformation imaging and rare cardiomyopathies with hypertrophic phenotype: a review focused on Fabry disease, Friedreich ataxia and amyloidosis
by: Bahaa Fadel, et al.
Published: (2013-06-01)

Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson–Fabry Disease
by: Antonino Tuttolomondo, et al.
Published: (2023-12-01)

Genetic screening of Fabry patients with EcoTILLING and HRM technology
by: Iemolo Francesco, et al.
Published: (2011-09-01)

Senza una multidisciplinarietà organizzata
by: Roberto Fanelli, et al.
Published: (2017-09-01)

Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
by: Kamil Stankowski, et al.
Published: (2023-11-01)

GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
by: Ândrea Virgínia Chaves-Markman, et al.

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
by: Edward Cheung, et al.
Published: (2021-12-01)

The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters
by: Maria V. Pisklova, et al.
Published: (2023-05-01)

Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study
by: Julia Treiber, et al.
Published: (2023-02-01)

Arrhythmogenic Left Ventricular Mass as the Initial Presentation of Cardiac Sarcoidosis
by: Erika Hutt, MD, et al.
Published: (2024-03-01)

Disseminated sarcoidosis involving lymph nodes, bone and spleen with progressive cardiac sarcoidosis on 18F-FDG PET/CT and cardiac MRI
by: James Yuheng Jiang, MD, MMed (ClinEpi), et al.
Published: (2021-11-01)

Advanced Imaging in Cardiac Amyloidosis
by: Dominik Waldmeier, et al.
Published: (2022-04-01)

The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients
by: Xiuzheng Yue, et al.
Published: (2022-10-01)

Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials
by: Mehrdad Rabiee Rad, et al.
Published: (2023-01-01)

ACE Genotype Distributions Differ between Sporadic and Familial Hypertrophic Cardiomyopathy
by: Ara Kassarjian, et al.
Published: (2020-12-01)

Anderson-Fabry: una malattia rara?
by: Paolo Colomba, et al.
Published: (2015-06-01)

Increased prevalence of peripheral vestibular disorder among patients with Fabry disease
by: Tzong-Hann Yang, et al.
Published: (2024-03-01)

Anderson-Fabry’s Disease: A Rare but Treatable Case of Fever of Unknown Origin
by: Francesca Graziani, et al.
Published: (2017-09-01)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
by: Francesca Graziani, et al.
Published: (2020-08-01)

Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy
by: Niccolò Maurizi, et al.
Published: (2023-04-01)

Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D
by: Melissa Herwig, et al.
Published: (2020-04-01)

A Structural Model of Transformation in Human Capital Management of the Army's Islamic Republic of Iran
by: Behnam Golshahi, et al.
Published: (2023-05-01)